Search Results - "KIECHLE, MARION"

Refine Results
  1. 1

    CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer by Bronger, Holger, Singer, Judith, Windmüller, Claudia, Reuning, Ute, Zech, Daniela, Delbridge, Claire, Dorn, Julia, Kiechle, Marion, Schmalfeldt, Barbara, Schmitt, Manfred, Avril, Stefanie

    Published in British journal of cancer (23-08-2016)
    “…Background: Tumour-infiltrating lymphocytes (TILs) are associated with improved survival in several epithelial cancers. The two chemokines CXCL9 and CXCL10…”
    Get full text
    Journal Article
  2. 2
  3. 3

    CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer by Seitz, Stefanie, Dreyer, Tobias F., Stange, Christoph, Steiger, Katja, Bräuer, Rosalinde, Scheutz, Leandra, Multhoff, Gabriele, Weichert, Wilko, Kiechle, Marion, Magdolen, Viktor, Bronger, Holger

    Published in British journal of cancer (01-06-2022)
    “…Background Response to immune checkpoint blockade (ICB) in ovarian cancer remains disappointing. Several studies have identified the chemokine CXCL9 as a…”
    Get full text
    Journal Article
  4. 4

    Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire by Hebestreit, Katrin, Yahiaoui-Doktor, Maryam, Engel, Christoph, Vetter, Walter, Siniatchkin, Michael, Erickson, Nicole, Halle, Martin, Kiechle, Marion, Bischoff, Stephan C

    Published in BMC cancer (18-05-2017)
    “…Health benefits of the Mediterranean Diet (MD) have been shown in different at-risk populations. A German translation of the Mediterranean Diet Adherence…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology by Drozdoff, Loisa, Klein, Evelyn, Kalder, Matthias, Brambs, Christine, Kiechle, Marion, Paepke, Daniela

    Published in Integrative cancer therapies (01-05-2019)
    “…Objective. The aim of this study was to assess the potential risks of interactions between biologically based complementary and alternative medication (BB-CAM)…”
    Get full text
    Journal Article
  8. 8

    Lifestyle modifications after the diagnosis of gynecological cancer by Paepke, Daniela, Wiedeck, Clea, Hapfelmeier, Alexander, Kiechle, Marion, Brambs, Christine

    Published in BMC women's health (28-06-2021)
    “…Background The influence of lifestyle factors on the quality of life, incidence and tumor recurrence has been evaluated in several studies and is gaining…”
    Get full text
    Journal Article
  9. 9

    Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer by Geng, Xiaocong, Liu, Yueyang, Diersch, Sandra, Kotzsch, Matthias, Grill, Sabine, Weichert, Wilko, Kiechle, Marion, Magdolen, Viktor, Dorn, Julia

    Published in PloS one (02-11-2017)
    “…KLK9, 10, 11, and 15 may represent potential cancer biomarkers for evaluating ovarian cancer prognosis. In the present study, we selected a homogeneous cohort…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors by Borm, Kai J, Loos, Maximilian, Oechsner, Markus, Mayinger, Michael C, Paepke, Daniela, Kiechle, Marion B, Combs, Stephanie E, Duma, Marciana N

    Published in Radiation oncology (London, England) (07-11-2018)
    “…This study was performed to evaluate skin toxicity during modern three-dimensional conformal radiotherapy (3D-CRT) and to evaluate the importance of dose…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Platelet mitochondrial membrane depolarization reflects disease severity in patients with preeclampsia by Kraemer, Bjoern F, Hennis, Irina, Karge, Anne, Kraemer, Anne Katrin, Dreyer, Tobias F, Kiechle, Marion, Kuschel, Bettina, Bronger, Holger

    Published in Molecular medicine (Cambridge, Mass.) (04-05-2022)
    “…Thrombocytopenia is a feared complication of preeclampsia (PE) that can additionally complicate the disease course and that carries a poor prognosis. The…”
    Get full text
    Journal Article
  14. 14

    The impact of fractionation on secondary malignancies in postoperative breast cancer irradiation by Kiesl, Sophia, Düsberg, Mathias, Behzadi, Sophie T., Moser, Rebecca, Nano, Jana, Huber, Thomas, Klein, Evelyn, Kiechle, Marion, Bernhardt, Denise, Combs, Stephanie E., Borm, Kai J.

    Published in Breast (Edinburgh) (01-12-2024)
    “…Randomized studies demonstrated the oncological equivalence of (ultra-)hypofractionation compared to a 5-week schedule in postoperative radiotherapy of breast…”
    Get full text
    Journal Article
  15. 15

    Simultaneous integrated boost within the lymphatic drainage system in breast cancer: A single center study on toxicity and oncologic outcome by Klusen, Sophie T, Peiler, Antonia, Schmidt, Georg P, Kiechle, Marion E, Muench, Stefan, Asadpour, Rebecca, Combs, Stephanie E, Borm, Kai J

    Published in Frontiers in oncology (06-04-2023)
    “…In breast cancer patients, the increasing de-escalation of axillary surgery and the improving resolution of diagnostic imaging results in a more frequent…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer by Gong, Weiwei, Liu, Yueyang, Seidl, Christof, Diamandis, Eleftherios P, Kiechle, Marion, Drecoll, Enken, Kotzsch, Matthias, Magdolen, Viktor, Dorn, Julia

    Published in BMC cancer (15-07-2019)
    “…In ovarian cancer, dysregulation of mRNA expression of several components of the family of the kallikrein-related peptidases (KLKs) is observed. In this study,…”
    Get full text
    Journal Article
  18. 18

    Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results by Noske, Aurelia, Anders, Sophie-Isabelle, Ettl, Johannes, Hapfelmeier, Alexander, Steiger, Katja, Specht, Katja, Weichert, Wilko, Kiechle, Marion, Klein, Evelyn

    Published in Breast (Edinburgh) (01-02-2020)
    “…Adjuvant chemotherapy decision in patients with hormone receptor positive, HER2 negative breast cancer (BC) is challenging. Ki-67 is widely used for adjuvant…”
    Get full text
    Journal Article
  19. 19
  20. 20